Another highly replicated finding in the brain of schizophrenia patients is a reduction in the expression of one of the biosynthetic enzymes of GABA, glutamate acid decarboxylase 67 (GAD67), along with other GABAergic markers (Dienel and Lewis, 2019). The gene discussed is GAD1; the disease is schizophrenia.